Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Kifissia – page 35

1 033 clinical trials in Kifissia, Greece across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

GreeceOur site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)
Kifissia at a glance
1 033
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

1 033 trials in Kifissia

Open in trial search

Thalassaemia beta+2

Not yet recruiting

Phase 3 study of mitapivat for effectiveness and safety in children with non‑transfusion‑dependent alpha or beta thalassemia

Investigational
Countries:GreeceGreece
  • Participants:0–17 years
  • Substances:Mitapivat
  • Sponsor:Agios Pharmaceuticals Inc.

Thalassaemia beta+2

Not yet recruiting

Phase 3 Study of Mitapivat to Reduce Transfusions in Children with Alpha or Beta Transfusion‑Dependent Thalassemia

Investigational
Countries:GreeceGreece
  • Participants:0–17 years
  • Substances:Mitapivat
  • Sponsor:Agios Pharmaceuticals Inc.

Amyloidosis

Not yet recruiting

Evaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:Bortezomib
  • Sponsor:Glaxosmithkline Research & Development Limited

Rhinitis

Not yet recruiting

Randomized study of ketotifen nasal spray (0.025% and 0.050%) versus sodium cromoglicate nasal spray in patients with rhinitis

Registered drug
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ketotifen
  • Sponsor:Eudemus Pharmaceuticals Limited

Ischaemic stroke

Not yet recruiting

Phase 2 Study of RADAMTS13 in Adults with Acute Ischemic Stroke

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:RADAMTS13
  • Sponsor:Takeda Development Center Americas Inc.

Sepsis

Not yet recruiting

Clarithromycin to prevent secondary infections in adult patients with community-acquired pneumonia-related sepsis

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Clarithromycin
  • Sponsor:Hellenic Institute For The Study Of Sepsis

Interstitial lung disease+2

Not yet recruiting

Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Bacterial infection+1

Not yet recruiting

A study to evaluate the use of meropenem to reduce the risk of sepsis in patients with suspected infection in the emergency department

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Meropenem Anhydrous
  • Sponsor:Hellenic Institute For The Study Of Sepsis

Embolism

Not yet recruiting

A study to compare REGN7508 and acetylsalicylic acid for preventing blood clots in adults undergoing elective total knee replacement.

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Regeneron Pharmaceuticals Inc.

Pulmonary fibrosis

Not yet recruiting

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Aciclovir
  • Sponsor:Regeneron Pharmaceuticals Inc.

Ischaemic stroke

Not yet recruiting

Study of Drug Combination with Amodiaquine and Potassium Canrenoate Plus Exenatide or Glibenclamide for Patients with Acute Ischemic Stroke

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Amodiaquine
  • Sponsor:Genesis Pharma S.A.

Other cities in Greece

The busiest research cities in the country

All 47 cities in Greece

Clinical research in Kifissia

What the registry says about research in the country

01 Oncology Research

Groundbreaking clinical trials focusing on non-small cell lung cancer and innovative treatment combinations. Studies evaluating novel therapies including immunotherapy agents and targeted treatments for various stages of cancer.

  • Advanced NSCLC Treatments
  • Breast Cancer Therapies
  • Gastrointestinal Cancer Studies

Multiple trials exploring combination therapies with chemotherapy and radiation for enhanced treatment outcomes.

02 Cardiovascular Studies

Important research in atrial fibrillation and stroke prevention, investigating new therapeutic approaches for cardiovascular conditions. Studies focusing on novel anticoagulants and heart attack treatments.

  • Stroke Prevention Therapies
  • Cardiac Rhythm Management
  • Acute Coronary Syndrome

Innovative treatments being evaluated to improve patient outcomes in emergency cardiovascular care.

03 Neurological Research

Clinical investigations targeting Alzheimer's disease and associated conditions, with a focus on managing psychosis and cognitive symptoms. Studies evaluating novel therapeutic approaches.

  • Alzheimer's Disease Treatments
  • Psychosis Management
  • Cognitive Function Studies

Dedicated research into improving quality of life for patients with neurodegenerative conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.